{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T10:28:38Z","timestamp":1769250518409,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008769","name":"Julius-Maximilians-Universit\u00e4t W\u00fcrzburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008769","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Anthocyanin-containing plant extracts and carotenoids, such as astaxanthin, have been well-known for their antiviral and anti-inflammatory activity, respectively. We hypothesised that a mixture of <jats:italic>Ribes nigrum L.<\/jats:italic> (Grossulariaceae) (common name black currant (BC)) and <jats:italic>Vaccinium myrtillus L.<\/jats:italic> (Ericaceae) (common name bilberry (BL)) extracts (BC\/BL) with standardised anthocyanin content as well as single plant extracts interfered with the replication of Measles virus and Herpesviruses in vitro.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We treated cell cultures with BC\/BL or defined single plant extracts, purified anthocyanins and astaxanthin in different concentrations and subsequently infected the cultures with the Measles virus (wild-type or vaccine strain Edmonston), Herpesvirus 1 or 8, or murine Cytomegalovirus. Then, we analysed the number of infected cells and viral infectivity and compared the data to non-treated controls.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The BC\/BL extract inhibited wild-type Measles virus replication, syncytia formation and cell-to-cell spread. This suppression was dependent on the wild-type virus-receptor-interaction since the Measles vaccine strain was unaffected by BC\/BL treatment. Furthermore, the evidence was provided that the delphinidin-3-rutinoside chloride, a component of BC\/BL, and purified astaxanthin, were effective anti-Measles virus compounds. Human Herpesvirus 1 and murine Cytomegalovirus replication was inhibited by BC\/BL, single bilberry or black currant extracts, and the BC\/BL component delphinidin-3-glucoside chloride. Additionally, we observed that BC\/BL seemed to act synergistically with aciclovir. Moreover, BC\/BL, the single bilberry and black currant extracts, and the BC\/BL components delphinidin-3-glucoside chloride, cyanidin-3-glucoside, delphinidin-3-rutinoside chloride, and petunidin-3-galactoside inhibited human Herpesvirus 8 replication.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our data indicate that Measles viruses and Herpesviruses are differentially susceptible to a specific BC\/BL mixture, single plant extracts, purified anthocyanins and astaxanthin. These compounds might be used in the prevention of viral diseases and in addition to direct-acting antivirals, such as aciclovir.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12906-022-03661-7","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T11:03:06Z","timestamp":1657278186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["A defined anthocyanin mixture sourced from bilberry and black currant inhibits Measles virus and various herpesviruses"],"prefix":"10.1186","volume":"22","author":[{"given":"Rinu","family":"Sivarajan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heike","family":"Oberwinkler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Roll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva-Maria","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Steinke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen","family":"Bodem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,8]]},"reference":[{"issue":"9811","key":"3661_CR1","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0140-6736(10)62352-5","volume":"379","author":"WJ Moss","year":"2012","unstructured":"Moss WJ, Griffin DE. Measles. Lancet. 2012;379(9811):153\u201364.","journal-title":"Lancet"},{"key":"3661_CR2","unstructured":"Robert Koch-Institute.\u00a0AKTUELLE DATEN UND INFORMATIONEN ZU INFEKTIONSKRANKHEITEN UND PUBLIC HEALTH.\u00a0Epidemiologisches Bulletin. 2020;1:14"},{"key":"3661_CR3","unstructured":"Zu infektionskrankheiten und public health. Epidemiologisches BulletinEpidemiologisches Bulletin. 2020;1:14."},{"issue":"4","key":"3661_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1542\/pir.30.4.119","volume":"30","author":"P Chayavichitsilp","year":"2009","unstructured":"Chayavichitsilp P, Buckwalter JV, Krakowski AC, Friedlander SF. Herpes simplex. Pediatr Rev. 2009;30(4):119\u201329 quiz 130.","journal-title":"Pediatr Rev"},{"issue":"4","key":"3661_CR5","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.coi.2012.04.002","volume":"24","author":"G Pawelec","year":"2012","unstructured":"Pawelec G, McElhaney JE, Aiello AE, Derhovanessian E. The impact of CMV infection on survival in older humans. Curr Opin Immunol. 2012;24(4):507\u201311.","journal-title":"Curr Opin Immunol"},{"issue":"6","key":"3661_CR6","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1002\/1097-0215(20001215)88:6<1003::AID-IJC26>3.0.CO;2-9","volume":"88","author":"EA Engels","year":"2000","unstructured":"Engels EA, Sinclair MD, Biggar RJ, Whitby D, Ebbesen P, Goedert JJ, Gastwirth JL. Latent class analysis of human herpesvirus 8 assay performance and infection prevalence in sub-saharan Africa and Malta. Int J Cancer. 2000;88(6):1003\u20138.","journal-title":"Int J Cancer"},{"key":"3661_CR7","unstructured":"Whitley RJ, Johnston C: Herpes Simplex Viruses: Pathogenesis and Clinical Insights, vol. 2. Philadelphia: Wolters Kluwer; 2022. p. 297\u2013321"},{"key":"3661_CR8","unstructured":"Arvin AM, Abendroth A. Cytomegalovirus, vol. 2. Philadelphia: Wolters Kluwer; 2022. p. 2022."},{"key":"3661_CR9","unstructured":"Guidelines Version 11 [https:\/\/www.eacsociety.org\/media\/final2021eacsguidelinesv11.0_oct2021.pdf]"},{"issue":"5","key":"3661_CR10","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.jhep.2012.12.008","volume":"58","author":"T Volz","year":"2013","unstructured":"Volz T, Allweiss L, Ben MM, Warlich M, Lohse AW, Pollok JM, Alexandrov A, Urban S, Petersen J, Lutgehetmann M, et al. The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus. J Hepatol. 2013;58(5):861\u20137.","journal-title":"J Hepatol"},{"issue":"2","key":"3661_CR11","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/hep.31060","volume":"71","author":"MG Ghany","year":"2020","unstructured":"Ghany MG, Morgan TR. Panel A-IHCG: Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Hepatology. 2020;71(2):686\u2013721.","journal-title":"Hepatology"},{"issue":"2","key":"3661_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/10408690590957188","volume":"46","author":"I Higuera-Ciapara","year":"2006","unstructured":"Higuera-Ciapara I, Felix-Valenzuela L, Goycoolea FM. Astaxanthin: a review of its chemistry and applications. Crit Rev Food Sci Nutr. 2006;46(2):185\u201396.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"4","key":"3661_CR13","doi-asserted-by":"publisher","first-page":"244","DOI":"10.15430\/JCP.2020.25.4.244","volume":"25","author":"H Han","year":"2020","unstructured":"Han H, Lim JW, Kim H. Astaxanthin Inhibits Helicobacter pylori-induced Inflammatory and Oncogenic Responses in Gastric Mucosal Tissues of Mice. J Cancer Prev. 2020;25(4):244\u201351.","journal-title":"J Cancer Prev"},{"issue":"3","key":"3661_CR14","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.bmc.2014.12.015","volume":"23","author":"LR de Sousa","year":"2015","unstructured":"de Sousa LR, Wu H, Nebo L, Fernandes JB, da Silva MF, Kiefer W, Kanitz M, Bodem J, Diederich WE, Schirmeister T, et al. Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: inhibition kinetics and docking studies. Bioorg Med Chem. 2015;23(3):466\u201370.","journal-title":"Bioorg Med Chem"},{"key":"3661_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12917-015-0459-9","volume":"11","author":"W Xiong","year":"2015","unstructured":"Xiong W, Ma X, Wu Y, Chen Y, Zeng L, Liu J, Sun W, Wang D, Hu Y. Determine the structure of phosphorylated modification of icariin and its antiviral activity against duck hepatitis virus A. BMC Vet Res. 2015;11:205.","journal-title":"BMC Vet Res"},{"key":"3661_CR16","doi-asserted-by":"crossref","unstructured":"Dai W, Bi J, Li F, Wang S, Huang X, Meng X, Sun B, Wang D, Kong W, Jiang C, et al. Antiviral Efficacy of Flavonoids against Enterovirus 71 Infection in Vitro and in Newborn Mice. Viruses. 2019;11(7):625.","DOI":"10.3390\/v11070625"},{"issue":"3","key":"3661_CR17","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1016\/j.tripleo.2011.04.007","volume":"112","author":"RJ Danaher","year":"2011","unstructured":"Danaher RJ, Wang C, Dai J, Mumper RJ, Miller CS. Antiviral effects of blackberry extract against herpes simplex virus type 1. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112(3):e31-35.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"3661_CR18","doi-asserted-by":"crossref","unstructured":"Di Sotto A, Di Giacomo S, Amatore D, Locatelli M, Vitalone A, Toniolo C, Rotino GL, Lo Scalzo R, Palamara AT, Marcocci ME, et al. A Polyphenol Rich Extract from Solanum melongena L. DR2 Peel Exhibits Antioxidant Properties and Anti-Herpes Simplex Virus Type 1 Activity In Vitro. Molecules 2018;23(8):2066.","DOI":"10.3390\/molecules23082066"},{"key":"3661_CR19","doi-asserted-by":"publisher","first-page":"27156","DOI":"10.1038\/srep27156","volume":"6","author":"U Grienke","year":"2016","unstructured":"Grienke U, Richter M, Walther E, Hoffmann A, Kirchmair J, Makarov V, Nietzsche S, Schmidtke M, Rollinger JM. Discovery of prenylated flavonoids with dual activity against influenza virus and Streptococcus pneumoniae. Sci Rep. 2016;6:27156.","journal-title":"Sci Rep"},{"issue":"1","key":"3661_CR20","first-page":"51","volume":"9","author":"L Nikolaeva-Glomb","year":"2014","unstructured":"Nikolaeva-Glomb L, Mukova L, Nikolova N, Badjakov I, Dincheva I, Kondakova V, Doumanova L, Galabov AS. In vitro antiviral activity of a series of wild berry fruit extracts against representatives of Picorna-. Orthomyxo- and Paramyxoviridae Nat Prod Commun. 2014;9(1):51\u20134.","journal-title":"Orthomyxo- and Paramyxoviridae Nat Prod Commun"},{"issue":"20","key":"3661_CR21","doi-asserted-by":"publisher","first-page":"6563","DOI":"10.1007\/s00216-013-7068-x","volume":"405","author":"K Swaminathan","year":"2013","unstructured":"Swaminathan K, Dyason JC, Maggioni A, von Itzstein M, Downard KM. Binding of a natural anthocyanin inhibitor to influenza neuraminidase by mass spectrometry. Anal Bioanal Chem. 2013;405(20):6563\u201372.","journal-title":"Anal Bioanal Chem"},{"key":"3661_CR22","doi-asserted-by":"crossref","unstructured":"Slimestad R, Solheim H. Anthocyanins from black currants (Ribes nigrum L.). J Agric Food Chem. 2002;50(11):3228\u201331.","DOI":"10.1021\/jf011581u"},{"issue":"2","key":"3661_CR23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nsmb.1969","volume":"18","author":"T Hashiguchi","year":"2011","unstructured":"Hashiguchi T, Ose T, Kubota M, Maita N, Kamishikiryo J, Maenaka K, Yanagi Y. Structure of the measles virus hemagglutinin bound to its cellular receptor SLAM. Nat Struct Mol Biol. 2011;18(2):135\u201341.","journal-title":"Nat Struct Mol Biol"},{"issue":"6","key":"3661_CR24","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1128\/JVI.02449-06","volume":"81","author":"M Tahara","year":"2007","unstructured":"Tahara M, Takeda M, Seki F, Hashiguchi T, Yanagi Y. Multiple amino acid substitutions in hemagglutinin are necessary for wild-type measles virus to acquire the ability to use receptor CD46 efficiently. J Virol. 2007;81(6):2564\u201372.","journal-title":"J Virol"},{"key":"3661_CR25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1472-6882-11-16","volume":"11","author":"C Krawitz","year":"2011","unstructured":"Krawitz C, Mraheil MA, Stein M, Imirzalioglu C, Domann E, Pleschka S, Hain T. Inhibitory activity of a standardized elderberry liquid extract against clinically-relevant human respiratory bacterial pathogens and influenza A and B viruses. BMC Complement Altern Med. 2011;11:16.","journal-title":"BMC Complement Altern Med"},{"issue":"2","key":"3661_CR26","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1006\/bbrc.2000.3485","volume":"276","author":"BQ Li","year":"2000","unstructured":"Li BQ, Fu T, Dongyan Y, Mikovits JA, Ruscetti FW, Wang JM. Flavonoid baicalin inhibits HIV-1 infection at the level of viral entry. Biochem Biophys Res Commun. 2000;276(2):534\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"3661_CR27","doi-asserted-by":"crossref","unstructured":"Dona G, Andrisani A, Tibaldi E, Brunati AM, Sabbadin C, Armanini D, Ambrosini G, Ragazzi E, Bordin L. Astaxanthin Prevents Human Papillomavirus L1 Protein Binding in Human Sperm Membranes. Mar Drugs. 2018;16(11):427.","DOI":"10.3390\/md16110427"},{"issue":"9","key":"3661_CR28","doi-asserted-by":"publisher","first-page":"4386","DOI":"10.1128\/JVI.01492-10","volume":"85","author":"LT Lin","year":"2011","unstructured":"Lin LT, Chen TY, Chung CY, Noyce RS, Grindley TB, McCormick C, Lin TC, Wang GH, Lin CC, Richardson CD. Hydrolyzable tannins (chebulagic acid and punicalagin) target viral glycoprotein-glycosaminoglycan interactions to inhibit herpes simplex virus 1 entry and cell-to-cell spread. J Virol. 2011;85(9):4386\u201398.","journal-title":"J Virol"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-022-03661-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-022-03661-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-022-03661-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T11:03:31Z","timestamp":1657278211000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-022-03661-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,8]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3661"],"URL":"https:\/\/doi.org\/10.1186\/s12906-022-03661-7","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,8]]},"assertion":[{"value":"18 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The present study was funded by Evonik Operations GmbH\/Medpalett AS which commercialises Healthberry 865\u00ae (BC\/BL). JB and MS are named inventors on Evonik Operations' patent applications for (1) Preparations containing berry extracts for use in the prophylaxis and\/or treatment of viral infections caused by Herpesviridae, (2) Combined preparation comprising an anthocyanin composition and an antiviral agent, (3) Preparations containing berry extracts for use in the prevention and\/or treatment of viral infections caused by Paramyxoviridae, and (4) Treatment and prevention of infections by Herpesviridae with Delphinidin-3-glucoside treatment and prevention of infections by Herpesviridae with berry extracts. JB works as a consultant for Evonik Operations GmbH. All other authors (RS, HO, VR and EMK) have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"181"}}